Bruce Feinberg, DO


Real-World Evidence and the Behavioral Economics of Physician Prescribing

April 28, 2017

The complex interplay of behavioral economics may result in reimbursement methodology alternatives to the prevailing fee-for-service payment system having less impact on prescribing behavior than has been conjectured.

Is There a Mathematical Resolution to the Cost-Versus-Value Debate?

December 11, 2015

Solutions proposed by patient advocates and physicians to control costs provide approaches to valuing new drug/treatments compared with 1 or several prevailing standards of care. Increasingly, however, the debate over cost is transitioning to a debate over value.